Human Burkitt lymphomas are divided into two main clinical variants: the endemic form, affecting African children infected with malaria and the Epstein-Barr virus, and the sporadic form, distributed across the rest of the world. However, whereas sporadic translocations decapitate Myc from 5′ proximal regulatory elements, most endemic events occur hundreds of kilobases away from Myc. The origin of these rearrangements and how they deregulate oncogenes at such distances remain unclear. We here recapitulate endemic Burkitt lymphoma-like translocations in plasmacytomas from uracil N-glycosylase and activation-induced cytidine deaminase-deficient mice. Mapping of translocation breakpoints using an acetylated histone H3 lysine 9 chromatin immunoprecipitation sequencing approach reveals Igh fusions up to ∼350 kb upstream of Myc or the related oncogene Mycn. A comprehensive analysis of epigenetic marks, PolII recruitment, and transcription in tumor cells demonstrates that the 3′ Igh enhancer (Eα) vastly remodels ∼450 kb of chromatin into translocated sequences, leading to significant polymerase occupancy and constitutive oncogene expression. We show that this longrange epigenetic reprogramming is directly proportional to the physical interaction of Eα with translocated sites. Our studies thus uncover the extent of epigenetic remodeling by Ig 3′ enhancers and provide a rationale for the long-range deregulation of translocated oncogenes in endemic Burkitt lymphomas. The data also shed light on the origin of endemic-like chromosomal rearrangements. chromosome conformation capture | chromosome translocations | activation-induced cytidine deamination | epigenetics
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chromosome conformation capture | chromosome translocations | activation-induced cytidine deamination | epigenetics D uring B-cell responses to antigen, somatic hypermutation (SHM) introduces point mutations at variable (V) genes, a process that, when coupled to clonal selection, can enhance the antibody's affinity for the antigen (1, 2) . Class switch recombination (CSR) is a second type of B-lymphocyte-specific DNA modification reaction that results in diversification of antibody effector functions by replacing the Igh constant domain Cμ with one of a set of downstream genes: Cγ, Cɛ, or Cα (3) (4) (5) . Both SHM and CSR are initiated by activation-induced cytidine deaminase (AID) (6, 7) , a B-cell-specific enzyme that deaminates cytidine residues to produce uracils (8) . Multiple repair pathways including uracil DNA glycosylase (UNG), mismatch repair enzymes, and error-prone polymerases process U:G mismatches into SHM or DNA double-strand breaks intermediate to CSR (3) (4) (5) 9) .
Although most AID-mediated lesions result in SHM or CSR, they can occasionally generate chromosome deletions, translocations, and aneuploidy (10) (11) (12) (13) (14) . These genomic abnormalities have the potential to deregulate oncogenes and thereby promote cell transformation. Perhaps the best-studied example is the translocation that juxtaposes Igh to the Myc proto-oncogene in human Burkitt lymphomas (BLs), mouse plasmacytomas (PCTs), and rat immunocytomas (15, 16) .
Human BLs are divided into two main clinical variants: the endemic form, affecting African children infected with malaria and the Epstein-Barr virus, and the sporadic form, distributed across the rest of the world (17) . Although both tumors are driven primarily by Igh/Myc rearrangements (18), the precise location of the breakpoints differs in the two subsets. In sporadic BLs (and mouse PCTs), translocations occur within Myc exon 1-intron 1, and as such they decapitate the oncogene from its 5′ regulatory elements (19) . These canonical rearrangements result from AID activity at IgS (during CSR) as well as at Myc (20) (21) (22) (23) . In contrast, endemic BL translocations are noncanonical in that they map hundreds of kilobases upstream from Myc basal promoters (24) (25) (26) (27) (28) . Because these lesions leave Myc upstream promoter elements intact, it is unclear how they bring about oncogene deregulation. The etiology of these events is also unknown, primarily because to date endemic BL-like translocations have not been systematically reproduced in the mouse.
Because of their proximity to V(D)J genes, endemic BL rearrangements have been proposed to arise as by-products of SHM but not of CSR (19, 27, 29) . On the basis of this idea and in an attempt to recapitulate endemic translocations in the mouse, we combined a UNG null allele (30) with the Bcl-xL transgene that produces plasma cell tumors (31) . In UNG −/− B cells, AID hypermutation remains active as evidenced by high levels of C-to-T mutation (32) . In contrast, CSR (32, 33) and canonical Igh/Myc translocations (34) are impaired because uracyl deglycosylation is an important intermediate step in double-strand DNA (dsDNA) break formation (12) . The UNG −/− mouse thus might be an ideal model to recapitulate rare, noncanonical translocations.
Consistent with a primary role for AID and UNG in the CSR breaks mediating Igh/Myc translocations (20, 23, 34) , we find that, in the absence of UNG, the incidence of B-cell transformation is markedly delayed. Strikingly, the vast majority of UNG −/− and AID −/− tumors that do develop carry endemic BL-like translocations with breakpoints accumulating over hundreds of kilobases upstream of Myc or its homolog the Mycn oncogene. Analysis of these tumors by deep-sequencing techniques sheds light on both the origin of endemic-like translocations and the genomic features that impact their tumor capacity. Bcl-xL mice, respectively (Fig. 1C ). In contrast, we failed to detect canonical T(12;15)s in any of the 216 DNAs isolated from UNG −/− Bcl-xL lymphoid tissues or oil granulomas (n = 216, Fig. 1C ). This discrepancy, which is consistent with previous ex vivo translocation studies (34), may be explained by the fact that dsDNA break formation at switch regions is decreased in the absence of UNG (35) (Fig. S2) . The results therefore demonstrate that plasmacytomagenesis in Bcl-xL transgenic mice that lack UNG resembles that observed in AID −/− mice in that it is not associated with canonical Igh/ Myc translocations. To precisely map the translocation breakpoints, we made use of high-resolution array comparative genomic hybridization (aCGH) and genome-wide chromatin immunoprecipitation sequencing (ChIP-Seq) for acetylated histone H3 lysine 9 (H3K9Ac). H3K9Ac is a chromatin mark associated with active transcription (36, 37) that allows one to detect unexpected discontinuities in active chromatin at translocation breakpoints. Bcl-xL translocations were directly within S domains, whereas all translocations isolated from wild-type tumors involved these sequences (Dataset S1). Despite these differences, Myc expression was comparable between Ung +/+ Bcl-xL and UNG −/− Bcl-xL tumors (Fig. 2D) . Finally, two UNG −/− Bcl-xL tumors did not bear rearrangements between chromosomes 12 and 15. One displayed a T(6;15) juxtaposing Igκ to the Myc-Pvt1 locus [tumor 6200 (Fig. S5 ) and +74 kb (Fig. 2C)] , and a second carried a chromosome 12 paracentric inversion (Inv12, tumor 7210, Fig. S6 ) that fused Sμ to the Mycn 3′ UTR, leading to overexpression of Mycn and transcriptional repression of Myc (Fig. S6) as previously described in similar tumors (31, 38) . On the basis of these findings we conclude that, in addition to decreasing the incidence and increasing the latency of malignant transformation, UNG deletion results in a shift of translocation breakpoints in chromosome 15 from the 3′ to the 5′ side of Myc TSS. one of ∼150 sites in the genome that suffer frequent AID-mediated DNA damage (39) (40) (41) . These data are consistent with the notion that most Igh/Myc translocations in PCTs in wild-type mice and in sporadic BL are the result of AID activity (23, 39, 40, 42) . In contrast to wild-type tumors, Igh translocations in UNGdeleted PCTs recapitulated the profile of rearrangements in human endemic BL in that breakpoints did not accumulate at well-defined hotspots but were instead distributed within a ∼350-kb domain 5′ of Myc (Fig. 3, II and III) . Within this window, the pattern closely resembled the random distribution of Igh translocations isolated from AID −/− primary B cells under nonselective conditions (Fig. 3, I ) (39) . These observations raise the possibility that translocations in tumors in UNG Fig. 3 , right dotted line), including a second AID-dependent hotspot at Pvt1 exon 5 (Fig. 3, VI) , truncate Myc-coding sequence or result in acentric chromosomes that are incompatible with cellular viability. Consistent with this view, such events have been detected only in short-term B-cell cultures under nonselective conditions (Fig. 3, I and VII) (39) . However, these features are unlikely to explain the 5′ boundary of rearrangements from UNG −/− PCT or endemic BL (depicted by the left dotted line in Fig. 3) . Instead, we reasoned that this boundary might reflect a threshold beyond which the Igh 3′Eα enhancer can no longer deregulate Myc or Mycn at a distance. In PCT from AID −/− or UNG −/− mice, these oncogenes were separated from 3′Eα by up to 400 kb ( Fig. 2C and Dataset S1), an observation that is highly consistent with distances observed in endemic BLs (28) .
Results

UNG
The 3′Eα regulatory region consists of multiple enhancer elements that mediate Igh gene expression in its physiological context (9, 43) and oncogene deregulation in translocated chromatin (44, 45) . To explore the extent and nature of 3′Eα long-range activity in PCTs, we first mapped the 3′Eα interactome by chromosome conformational capture coupled with deep sequencing (4C-Seq) (41, 46) . As bait, we used a DNA sequence within 3′Eα (Materials and Methods) and constructed four independent 4C libraries from Myc and Mycn-driven PCTs. Resting and activated primary B cells were also included in the analyses. Remarkably, we found 3′Eα local interactions to be asymmetrically biased to 5′ sequences in all cases (Fig. 4, I and II). This unequal distribution can be explained by the presence of a documented CTCF-binding domain ∼4 kb 3′ of the enhancer (Fig. 4, III) , which has been proposed to insulate downstream non-Ig genes from 3′Eα activity (47) . In both tumors, the average contact frequency for 3′Eα across the entire cis-chromosome declined monotonically as a function of distance (Fig. S7) . Between 0.1 and 10 Mb from the bait, for example, 4C-Seq reads showed a power law scaling with an exponent of −1.19 (Fig. S7) , which is in good agreement with that calculated in primary B cells using the same bait (−1.06) (41) . This correlation indicates that chromosomal translocations do not appreciably alter the local contact profiles of 3′Eα. To estimate the functional genomic reach of 3′Eα, we compared its average contact frequency at translocated Myc and Mycn loci with that measured downstream of the putative insulator where 3′Eα is not known to modulate gene expression. Despite the fact that the distance between 3′Eα and the oncogenes was markedly different in the two tumors (15 kb for Myc and 226 kb for Mycn, Dataset S1), the analysis showed very similar results. In the Myc PCT, the 5′ and 3′ average contact frequencies intersected ∼460 kb 5′ of the 4C-Seq bait, whereas in the Mycn tumor, the intersection occurred at ∼480 kb (Fig. 4, I and II, respectively). These data predict that 3′Eα must influence gene expression over distances of at least 450 kb. To directly test this idea, we used deep sequencing to measure PolII, mRNA, and nine activating chromatin modifications (H2AZ, H2BK5Ac, H2BK120Ac, H3K4me3, H3K36me2, H3K9Ac, H3K27Ac, H4K8Ac, and H4K91Ac) in primary activated B cells and the Mycn tumor. This PCT was chosen for further study because, in contrast to Myc, the Mycn locus is transcriptionally silent in peripheral B cells (22) . As expected, Mycn was inactive in cultured B cells stimulated with LPS+IL4 as evidenced by the absence of Pol II recruitment and mRNA synthesis at the locus (Fig. S8, I and II). In contrast, we found high levels of PolII and mRNA at Mycn and the nearby DV652083 EST in the translocated tumor cells (Fig. S8, III and IV) . Consistent with these findings, the translocated locus was associated with activating epigenetic modifications, which could be clustered into two distinct groups. H3K4me3, H2BK5Ac, H3K9Ac, and H3K27Ac were circumscribed to Mycn, DV652083, and the 3′Eα enhancer (Fig. 5, I ). In contrast, H2AZ, H2BK120Ac, H3K36me2, H4K8Ac, and H4K91Ac extended as a group uninterruptedly for about 450 kb from 3′Eα across the entire Ch locus into the translocated domain (Fig. 5, II) . Beyond this point, no substantial differences were found in PolII recruitment, gene expression, or epigenetic modifications between primary and tumor cells. Importantly, these modifications were not present at the Mycn locus in primary activated B cells (Fig. 5, III) . The findings are thus consistent with the notion that 3′Eα remodels ∼0.45 Mb of translocated chromatin, an estimate that agrees well with its predicted functional contact profile (Fig. 4) and the maximum distance separating 3′Eα from Myc or Mycn in PCTs and endemic BLs (Fig. 3 and Dataset S1).
Discussion
Early cytogenetic analyses of sporadic BL demonstrated that translocation breakpoints at Myc accumulate at a well-defined hotspot comprising promoter-proximal sequences and most of intron 1 (24, 27, 28, 48) . Several lines of evidence have since ascribed translocations at this site to AID activity. First, the Myc hotspot physically overlaps with the recruitment profile of AID (22) and its cofactor Spt5 (49) . Spt5 plays an active role in RNA PolII stalling, and, as such, it is believed to facilitate AID interaction with single-stranded DNA (its physiological target) at PolII-stalling sites both in Ig and non-Ig genes (50) . Consistent with this idea, the Myc translocation hotspot in stimulated B cells displays extensive PolII stalling (49) and accumulates substantial hypermutation and dsDNA breaks in an AID-dependent manner (22, 41, 51) . Formal proof that these lesions directly promote Igh/Myc rearrangements was recently provided by gene-targeting studies (23) and genome-wide maps of B-cell translocations generated under nonselective conditions (39, 40) . In both cases, the sporadic BL translocation hotspot at Myc was recapitulated in AID +/+ but not in AID −/− primary mouse B cells, supporting the contention that AID directly targets Myc.
In contrast to translocations found in sporadic BL, translocations characteristic of endemic BL do not accumulate preferentially at Myc promoter-proximal sequences. Instead, they are scattered across several hundred kilobases 5′ of Myc TSS with no obvious bias for switch recombination homology sequences or known AID hotspots, although these are not as well defined in humans as in mice (24, 27, 28, 48) . Also in contrast to sporadic BL translocations, endemic events rarely involve IgS domains, but appear to accumulate in the vicinity of Jh sequences (19) . A key aspect of our findings is that we have recapitulated endemic BL-like translocations in the absence of UNG. Analogous to the human tumors, translocation breakpoints in UNG −/− PCTs are distributed over hundreds of kilobases upstream of Myc TSS and do not display the strict bias for IgS domains seen in wild-type mice. Importantly, a similar distribution of translocation breakpoints was isolated from rare AID −/− tumors that occur in Bcl-xl transgenic mice injected with pristane. Considering these similarities, it is likely that endemic-like rearrangements in both mouse strains are generated by the same nontargeted mechanism, which remains to be characterized.
During CSR, 3′Eα elements regulate transcription of targeted Ch domains at large distances (52) . Mechanistically, this activity correlates with direct physical interactions between 3′Eα, I promoters, and Eμ (53, 54) , analogous to nuclear contacts observed at the β-globin loci and other enhancer-promoter systems (55) . In B-cell tumors, 3′Eα is not needed for the development of chromosomal translocations per se, but it physically associates with rearranged oncogenes (56) and is required for their longrange activation (45) . To measure the functional genomic reach of 3′Eα, we have mapped its interactome and the epigenetic alterations induced at translocated chromatin via 4C-Seq and ChIP-Seq. Our results demonstrate that 3′Eα interacts with and reprograms up to 0.45 Mb of translocated chromatin. Notably, the span of this interaction was comparable regardless of the distance separating 3′Eα from Myc or Mycn. This observation suggests that the topological constraints imposed by 3′Eα on chromatin are mostly independent of gene composition or location. Under this scenario, we find it useful to envision 3′Eα as "warping" nearly half a megabase of chromatin space, with oncogenes being deregulated by translocations that occur only within such a genomic window (Fig. 6 ). In the context of endemic BL and UNG −/− PCT, this scenario explains the 5′ boundary of selected translocation breakpoints, which reflect the upper limit of 3′Eα long-range oncogenic activity.
It is important to point out that, under different developmental settings, 3′Eα may engage in substantially longer functional contacts. During V(D)J recombination in immature B cells, for example, 3′Eα forms a chromatin hub with recombining diversity and variable domains, which are positioned in some instances more than 2 Mb away (57) (58) (59) . This stage-specific locus contraction occurs via DNA looping and appears to be mediated by specialized transcription factors, cohesin, and CTCF, all of which assemble at dedicated domains within the heavy chain locus (57, 58, 60, 61) . For the most part, these sequences are deleted by functional V(D)J joints and thus have not been reported in translocated Igh alleles. One exception is hs5-7, which spans ∼10 kb of DNA downstream of 3′Eα and displays insulating functions in reporter constructs (47) . Consistent with such activity, we now show that 3′Eα local interactions are asymmetrically biased to 5′ sequences. Presumably, 3′ non-Ig genes are protected by hs5-7 from 3′Eα potent transcriptional enhancing activity. Although unproven, this idea is attractive because it helps explain how 3′Eα deregulates 5′-translocated oncogenes at very long distances whereas proximal (3′) non-Ig genes are unaffected. By the same token, the presence of an insulator downstream of Igh would also explain the observation that, even though Myc translocates on both sides of 3′Eα in primary B cells (39) , only 5′ events are selected during tumorigenesis. A direct test of these ideas awaits genetic deletion of the putative hs5-7 insulator. 0.5Mb Fig. 6 . "Warping" model of 3′Eα activity. Our studies indicate that the 3′Eα acts over half a megabase of chromatin space, with oncogenes such as Myc being deregulated by translocations that fall within this genomic window. Non-Ig genes downstream of the enhancer might be protected from 3′Eα activity by the hs5-7 insulator.
Materials and Methods
SI Materials and Methods contains detailed information on plasmacytomagenesis induction; microscopy characterization of plasma cell foci; quantitative PCR measurements of Myc and Mycn expression; ChIP-Seq of chromatin modifications (Fig. S9) ; amplification of translocations by PCR; ex vivo B-cell activation conditions; FISH, SKY, and aCGH analysis of tumors; 4C-and mRNASeq experiments; and bioinformatics analyses of all genomic datasets. Details on spectral karyotyping are provided. Sequences of primers used in the various PCR reactions are also included.
